|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
TYSY-1-E |
Thymidylate Synthase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
10000 |
0.35 |
Binding ≤ 10μM
|
Z81034-1-O |
A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6000 |
0.37 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.29 |
0.57 |
-12.33 |
0 |
4 |
0 |
43 |
280.718 |
1 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80583-3-O |
Vero (Kidney Cells) (cluster #3 Of 3), Other |
Other |
1200 |
0.35 |
ADME/T ≤ 10μM
|
Z80612-1-O |
2008 (Ovarian Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2500 |
0.33 |
ADME/T ≤ 10μM
|
Z81034-1-O |
A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
4700 |
0.31 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.30 |
9.83 |
-12.02 |
0 |
4 |
0 |
43 |
348.715 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z81034-1-O |
A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
9000 |
0.29 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.73 |
3.67 |
-16.47 |
0 |
4 |
0 |
43 |
332.26 |
2 |
↓
|
|
|
Analogs
-
3917708
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AURKA-1-E |
Serine/threonine-protein Kinase Aurora-A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
40 |
0.27 |
Binding ≤ 10μM |
MMP2-2-E |
72 KDa Type IV Collagenase (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
1100 |
0.21 |
Binding ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.22 |
Binding ≤ 10μM
|
TOP1-1-E |
DNA Topoisomerase I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
Z50643-2-O |
Hepatitis C Virus (cluster #2 Of 2), Other |
Other |
2600 |
0.20 |
Binding ≤ 10μM
|
Z103196-1-O |
22RV1 (cluster #1 Of 2), Other |
Other |
1300 |
0.21 |
Functional ≤ 10μM |
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
130 |
0.25 |
Functional ≤ 10μM
|
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
370 |
0.23 |
Functional ≤ 10μM
|
Z103219-1-O |
Ca9-22 (cluster #1 Of 1), Other |
Other |
1300 |
0.21 |
Functional ≤ 10μM
|
Z50347-3-O |
Saccharomyces Cerevisiae (cluster #3 Of 3), Other |
Other |
10000 |
0.18 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z50643-2-O |
Hepatitis C Virus (cluster #2 Of 5), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z80008-1-O |
5637 (Epithelial Bladder Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80017-1-O |
A2780cisR (Cisplatin-resistant Ovarian Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6 |
0.30 |
Functional ≤ 10μM
|
Z80018-2-O |
A-375 (Malignant Melanoma Cells) (cluster #2 Of 4), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM |
Z80021-3-O |
A498 (Renal Carcinoma Cells) (cluster #3 Of 5), Other |
Other |
53 |
0.26 |
Functional ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
700 |
0.22 |
Functional ≤ 10μM |
Z80026-1-O |
AGS (Gastric Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
310 |
0.23 |
Functional ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 7), Other |
Other |
8 |
0.29 |
Functional ≤ 10μM
|
Z80039-1-O |
BGC-823 (Stomach Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
1000 |
0.22 |
Functional ≤ 10μM
|
Z80052-1-O |
C8166 (Leukemic T-cells) (cluster #1 Of 3), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM |
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80068-1-O |
CCRF-SB (Lymphoblastic Leukemia Cells) (cluster #1 Of 5), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80088-1-O |
CHO (Ovarian Cells) (cluster #1 Of 4), Other |
Other |
6000 |
0.19 |
Functional ≤ 10μM
|
Z80092-1-O |
CHO-K1 (Ovarian Cells) (cluster #1 Of 2), Other |
Other |
400 |
0.23 |
Functional ≤ 10μM
|
Z80105-2-O |
COR-L23 (Lung Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
319 |
0.23 |
Functional ≤ 10μM
|
Z80114-1-O |
Daudi (Burkitts Lymphoma Cells) (cluster #1 Of 4), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
2540 |
0.20 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
6240 |
0.19 |
Functional ≤ 10μM |
Z80126-2-O |
DuPro (cluster #2 Of 2), Other |
Other |
1800 |
0.21 |
Functional ≤ 10μM
|
Z80138-1-O |
G-361 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80145-3-O |
H69 (cluster #3 Of 4), Other |
Other |
870 |
0.22 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
920 |
0.22 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
940 |
0.22 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
4700 |
0.19 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
9320 |
0.18 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
92 |
0.25 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
950 |
0.22 |
Functional ≤ 10μM
|
Z80175-1-O |
IMR-32 (Neuroblastoma Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
430 |
0.23 |
Functional ≤ 10μM
|
Z80188-1-O |
KB 3-1 (Cervical Epithelial Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
21 |
0.28 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
900 |
0.22 |
Functional ≤ 10μM |
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
200 |
0.24 |
Functional ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
9700 |
0.18 |
Functional ≤ 10μM
|
Z80214-2-O |
M14 (Melanoma Cells) (cluster #2 Of 3), Other |
Other |
820 |
0.22 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
80 |
0.25 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
920 |
0.22 |
Functional ≤ 10μM
|
Z80227-1-O |
MCF7-ADR (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM
|
Z80240-1-O |
MDA-MB-361 (cluster #1 Of 1), Other |
Other |
33 |
0.27 |
Functional ≤ 10μM
|
Z80243-1-O |
MDA-MB-453 (Breast Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
120 |
0.25 |
Functional ≤ 10μM
|
Z80244-4-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #4 Of 7), Other |
Other |
7 |
0.29 |
Functional ≤ 10μM
|
Z80254-1-O |
MES-SA (Uterine Sarcoma Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80255-2-O |
MES-SA/DxS (Uterine Sarcoma Cells) (cluster #2 Of 2), Other |
Other |
704 |
0.22 |
Functional ≤ 10μM
|
Z80267-1-O |
MKN-1 (cluster #1 Of 1), Other |
Other |
640 |
0.22 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
3130 |
0.20 |
Functional ≤ 10μM
|
Z80285-2-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z80295-6-O |
MT4 (Lymphocytes) (cluster #6 Of 8), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80322-2-O |
NCI-H358 (Lung Carcinama Cells) (cluster #2 Of 2), Other |
Other |
620 |
0.22 |
Functional ≤ 10μM
|
Z80330-1-O |
NCI-N87 (cluster #1 Of 1), Other |
Other |
420 |
0.23 |
Functional ≤ 10μM
|
Z80354-4-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #4 Of 4), Other |
Other |
35 |
0.27 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
17 |
0.28 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
830 |
0.22 |
Functional ≤ 10μM |
Z80364-1-O |
P388/ADR (Lymphoma Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80367-1-O |
P388/S (cluster #1 Of 1), Other |
Other |
13 |
0.28 |
Functional ≤ 10μM
|
Z80389-1-O |
PC-14 (cluster #1 Of 1), Other |
Other |
290 |
0.23 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
680 |
0.22 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
912 |
0.22 |
Functional ≤ 10μM
|
Z80414-1-O |
Raji (B-lymphoblastic Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80433-1-O |
RPMI-8226 (Multiple Myeloma Cells) (cluster #1 Of 3), Other |
Other |
560 |
0.22 |
Functional ≤ 10μM
|
Z80441-1-O |
RXF 944 (cluster #1 Of 1), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80466-1-O |
SF268 (cluster #1 Of 4), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z80468-1-O |
SF-295 (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
35 |
0.27 |
Functional ≤ 10μM
|
Z80472-1-O |
SiHa (Cervical Squamous Cell Carcinoma) (cluster #1 Of 2), Other |
Other |
500 |
0.23 |
Functional ≤ 10μM
|
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80477-1-O |
SK_HEP1 (Hepatoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z80479-1-O |
SK-MEL (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
1730 |
0.21 |
Functional ≤ 10μM
|
Z80481-1-O |
SK-MEL-1 (Metastatic Melanoma Cells) (cluster #1 Of 1), Other |
Other |
3092 |
0.20 |
Functional ≤ 10μM |
Z80482-3-O |
SK-MEL-2 (Melanoma Cells) (cluster #3 Of 4), Other |
Other |
97 |
0.25 |
Functional ≤ 10μM
|
Z80485-1-O |
SK-MEL-28 (Melanoma Cells) (cluster #1 Of 6), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z80490-3-O |
SK-MES-1 (cluster #3 Of 4), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80491-2-O |
SK-N-MC (Neuroepithelioma Cells) (cluster #2 Of 4), Other |
Other |
120 |
0.25 |
Functional ≤ 10μM
|
Z80492-1-O |
SK-N-SH (Neuroblastoma Cells) (cluster #1 Of 2), Other |
Other |
1100 |
0.21 |
Functional ≤ 10μM
|
Z80493-1-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
800 |
0.22 |
Functional ≤ 10μM
|
Z80495-1-O |
SK-VLB (cluster #1 Of 1), Other |
Other |
6540 |
0.19 |
Functional ≤ 10μM
|
Z80503-1-O |
SNU1 (cluster #1 Of 2), Other |
Other |
4000 |
0.19 |
Functional ≤ 10μM
|
Z80509-1-O |
SNU-638 (Gastric Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
690 |
0.22 |
Functional ≤ 10μM
|
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM |
Z80532-1-O |
T-24 (Bladder Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
640 |
0.22 |
Functional ≤ 10μM
|
Z80559-1-O |
U251 (cluster #1 Of 3), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80560-1-O |
U-251 (Glioma Cells) (cluster #1 Of 3), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80563-1-O |
U-373 MG ( Glioblastoma Cells) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80565-1-O |
U-87 MG (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80574-2-O |
UMUC3 (cluster #2 Of 2), Other |
Other |
9 |
0.29 |
Functional ≤ 10μM
|
Z80581-1-O |
VA13 (cluster #1 Of 1), Other |
Other |
400 |
0.23 |
Functional ≤ 10μM
|
Z80581-1-O |
VA13 (cluster #1 Of 1), Other |
Other |
699 |
0.22 |
Functional ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 7), Other |
Other |
5000 |
0.19 |
Functional ≤ 10μM
|
Z80595-1-O |
WIL2-NS (Lymphoblastoid Cells) (cluster #1 Of 2), Other |
Other |
200 |
0.24 |
Functional ≤ 10μM |
Z80600-2-O |
XF498 (Glioma Cells) (cluster #2 Of 2), Other |
Other |
44 |
0.26 |
Functional ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
9 |
0.29 |
Functional ≤ 10μM
|
Z80640-1-O |
786-0 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
3100 |
0.20 |
Functional ≤ 10μM |
Z80661-1-O |
A704 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2000 |
0.20 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
540 |
0.22 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
970 |
0.22 |
Functional ≤ 10μM
|
Z80697-1-O |
Bel-7402 (Hepatoma Cells) (cluster #1 Of 3), Other |
Other |
1000 |
0.22 |
Functional ≤ 10μM
|
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
72 |
0.26 |
Functional ≤ 10μM
|
Z80726-1-O |
TRAMP-C1A (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
76 |
0.26 |
Functional ≤ 10μM
|
Z80730-1-O |
C2D Cell Line (cluster #1 Of 1), Other |
Other |
47 |
0.26 |
Functional ≤ 10μM
|
Z80731-1-O |
C2G Cell Line (cluster #1 Of 1), Other |
Other |
29 |
0.27 |
Functional ≤ 10μM
|
Z80732-1-O |
TRAMP-C2H (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80735-1-O |
C38 (Colon Carcinoma) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80768-1-O |
CH1 (Ovarian Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
6 |
0.30 |
Functional ≤ 10μM
|
Z80784-1-O |
Col2 (Colon Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
520 |
0.23 |
Functional ≤ 10μM
|
Z80801-2-O |
CRL-7065 Cell Line (cluster #2 Of 2), Other |
Other |
500 |
0.23 |
Functional ≤ 10μM
|
Z80819-1-O |
J774.2 (cluster #1 Of 1), Other |
Other |
368 |
0.23 |
Functional ≤ 10μM |
Z80846-1-O |
F460pv8/eto Cell Line (cluster #1 Of 2), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80852-1-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80887-1-O |
H2981 Cell Line (cluster #1 Of 1), Other |
Other |
700 |
0.22 |
Functional ≤ 10μM
|
Z80889-1-O |
NCI-H322M (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80896-1-O |
NCI-H69 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
27 |
0.27 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
6810 |
0.19 |
Functional ≤ 10μM
|
Z80936-1-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #1 Of 4), Other |
Other |
900 |
0.22 |
Functional ≤ 10μM |
Z80943-1-O |
HEL 299 (cluster #1 Of 1), Other |
Other |
1700 |
0.21 |
Functional ≤ 10μM |
Z80945-1-O |
HEp-2 (Laryngeal Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
59 |
0.26 |
Functional ≤ 10μM
|
Z81005-1-O |
HTB-54 Cell Line (cluster #1 Of 1), Other |
Other |
1100 |
0.21 |
Functional ≤ 10μM
|
Z81006-1-O |
Human Breast 401NL Tumor Cell Line (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z81017-1-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
620 |
0.22 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
954 |
0.22 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
1290 |
0.21 |
Functional ≤ 10μM |
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
660 |
0.22 |
Functional ≤ 10μM
|
Z81025-1-O |
Human Lung LXF 529L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z81026-1-O |
Human Lung LXF 629L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z81028-1-O |
Human Melanoma Cell Line (cluster #1 Of 1), Other |
Other |
280 |
0.24 |
Functional ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 10), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z81043-1-O |
N592 (cluster #1 Of 2), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81054-1-O |
SF-268 (Glioblastoma Cells) (cluster #1 Of 3), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z81101-1-O |
KBM-3 Cell Line (cluster #1 Of 1), Other |
Other |
26 |
0.27 |
Functional ≤ 10μM
|
Z81102-1-O |
KBM-3/DOX Cell Line (cluster #1 Of 1), Other |
Other |
490 |
0.23 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
7010 |
0.19 |
Functional ≤ 10μM
|
Z81133-1-O |
L1210 (1565) (cluster #1 Of 1), Other |
Other |
315 |
0.23 |
Functional ≤ 10μM |
Z81134-1-O |
L2987 (Lung Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z81160-1-O |
Lewis Lung Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81164-1-O |
LL Cell Line (cluster #1 Of 2), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81167-1-O |
LLTC Cell Line (cluster #1 Of 1), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
78 |
0.26 |
Functional ≤ 10μM
|
Z81184-1-O |
LOX IMVI (Melanoma Cells) (cluster #1 Of 5), Other |
Other |
42 |
0.26 |
Functional ≤ 10μM
|
Z81201-1-O |
HOP-62 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
4 |
0.30 |
Functional ≤ 10μM
|
Z81211-1-O |
LXFL529 Cell Line (cluster #1 Of 1), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 1), Other |
Other |
79 |
0.25 |
Functional ≤ 10μM |
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
960 |
0.22 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
710 |
0.22 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
730 |
0.22 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
840 |
0.22 |
Functional ≤ 10μM
|
Z81257-1-O |
MEL-AC Cell Line (cluster #1 Of 1), Other |
Other |
1200 |
0.21 |
Functional ≤ 10μM
|
Z81261-1-O |
UACC-375 (cluster #1 Of 1), Other |
Other |
112 |
0.25 |
Functional ≤ 10μM
|
Z81277-2-O |
NCI-N417 (cluster #2 Of 2), Other |
Other |
230 |
0.24 |
Functional ≤ 10μM
|
Z81280-1-O |
NCI-H226 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
8 |
0.29 |
Functional ≤ 10μM
|
Z81284-1-O |
NCI-H647 (cluster #1 Of 2), Other |
Other |
1 |
0.32 |
Functional ≤ 10μM
|
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
80 |
0.25 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
820 |
0.22 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
2320 |
0.20 |
Functional ≤ 10μM
|
Z81341-1-O |
Tumor Cell Lines (cluster #1 Of 1), Other |
Other |
74 |
0.26 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 2), Other |
Other |
500 |
0.23 |
ADME/T ≤ 10μM
|
Z80002-1-O |
1A9 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
100 |
0.25 |
ADME/T ≤ 10μM
|
Z80005-1-O |
3T3 (Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
3700 |
0.19 |
ADME/T ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.25 |
ADME/T ≤ 10μM
|
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
600 |
0.22 |
ADME/T ≤ 10μM |
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 2), Other |
Other |
60 |
0.26 |
ADME/T ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
480 |
0.23 |
ADME/T ≤ 10μM
|
Z80178-2-O |
J774.A1 (Macrophage Cells) (cluster #2 Of 2), Other |
Other |
20 |
0.28 |
ADME/T ≤ 10μM |
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 3), Other |
Other |
60 |
0.26 |
ADME/T ≤ 10μM
|
Z80193-3-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #3 Of 4), Other |
Other |
29 |
0.27 |
ADME/T ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
33 |
0.27 |
ADME/T ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
70 |
0.26 |
ADME/T ≤ 10μM
|
Z80253-2-O |
MEF (Embryonic Fibroblast Cells) (cluster #2 Of 2), Other |
Other |
3400 |
0.20 |
ADME/T ≤ 10μM
|
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
300 |
0.23 |
ADME/T ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
2000 |
0.20 |
ADME/T ≤ 10μM
|
Z80548-2-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
8 |
0.29 |
ADME/T ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 3), Other |
Other |
7400 |
0.18 |
ADME/T ≤ 10μM
|
Z80682-2-O |
A549 (Lung Carcinoma Cells) (cluster #2 Of 3), Other |
Other |
900 |
0.22 |
ADME/T ≤ 10μM
|
Z80704-1-O |
BJ (Foreskin Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
2700 |
0.20 |
ADME/T ≤ 10μM
|
Z80936-4-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #4 Of 4), Other |
Other |
64 |
0.26 |
ADME/T ≤ 10μM
|
Z81020-1-O |
HepG2 (Hepatoblastoma Cells) (cluster #1 Of 1), Other |
Other |
420 |
0.23 |
ADME/T ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
ADME/T ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
7 |
0.29 |
ADME/T ≤ 10μM
|
Z81057-5-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #5 Of 5), Other |
Other |
30 |
0.27 |
ADME/T ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 3), Other |
Other |
400 |
0.23 |
ADME/T ≤ 10μM
|
Z81331-2-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #2 Of 2), Other |
Other |
178 |
0.24 |
ADME/T ≤ 10μM
|
Q7ZJM1-1-V |
Human Immunodeficiency Virus Type 1 Integrase (cluster #1 Of 6), Viral |
Viruses |
900 |
0.22 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.57 |
-0.88 |
-58.15 |
8 |
12 |
1 |
208 |
544.533 |
5 |
↓
|
|
|
Analogs
-
3830631
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AURKA-1-E |
Serine/threonine-protein Kinase Aurora-A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
40 |
0.27 |
Binding ≤ 10μM |
MMP2-2-E |
72 KDa Type IV Collagenase (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
1100 |
0.21 |
Binding ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.22 |
Binding ≤ 10μM
|
TOP1-1-E |
DNA Topoisomerase I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
Z50643-2-O |
Hepatitis C Virus (cluster #2 Of 2), Other |
Other |
2600 |
0.20 |
Binding ≤ 10μM
|
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
130 |
0.25 |
Functional ≤ 10μM
|
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
370 |
0.23 |
Functional ≤ 10μM
|
Z103219-1-O |
Ca9-22 (cluster #1 Of 1), Other |
Other |
1300 |
0.21 |
Functional ≤ 10μM
|
Z50347-3-O |
Saccharomyces Cerevisiae (cluster #3 Of 3), Other |
Other |
10000 |
0.18 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z50643-2-O |
Hepatitis C Virus (cluster #2 Of 5), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z80008-1-O |
5637 (Epithelial Bladder Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80017-1-O |
A2780cisR (Cisplatin-resistant Ovarian Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6 |
0.30 |
Functional ≤ 10μM
|
Z80018-2-O |
A-375 (Malignant Melanoma Cells) (cluster #2 Of 4), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM |
Z80021-3-O |
A498 (Renal Carcinoma Cells) (cluster #3 Of 5), Other |
Other |
53 |
0.26 |
Functional ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
700 |
0.22 |
Functional ≤ 10μM |
Z80026-1-O |
AGS (Gastric Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
310 |
0.23 |
Functional ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 7), Other |
Other |
8 |
0.29 |
Functional ≤ 10μM
|
Z80039-1-O |
BGC-823 (Stomach Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
1000 |
0.22 |
Functional ≤ 10μM
|
Z80052-1-O |
C8166 (Leukemic T-cells) (cluster #1 Of 3), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM |
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80068-1-O |
CCRF-SB (Lymphoblastic Leukemia Cells) (cluster #1 Of 5), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80088-1-O |
CHO (Ovarian Cells) (cluster #1 Of 4), Other |
Other |
6000 |
0.19 |
Functional ≤ 10μM
|
Z80092-1-O |
CHO-K1 (Ovarian Cells) (cluster #1 Of 2), Other |
Other |
400 |
0.23 |
Functional ≤ 10μM
|
Z80105-2-O |
COR-L23 (Lung Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
319 |
0.23 |
Functional ≤ 10μM
|
Z80114-1-O |
Daudi (Burkitts Lymphoma Cells) (cluster #1 Of 4), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
6240 |
0.19 |
Functional ≤ 10μM |
Z80126-2-O |
DuPro (cluster #2 Of 2), Other |
Other |
1800 |
0.21 |
Functional ≤ 10μM
|
Z80138-1-O |
G-361 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80145-3-O |
H69 (cluster #3 Of 4), Other |
Other |
870 |
0.22 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
920 |
0.22 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
9320 |
0.18 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
92 |
0.25 |
Functional ≤ 10μM
|
Z80175-1-O |
IMR-32 (Neuroblastoma Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80188-1-O |
KB 3-1 (Cervical Epithelial Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
21 |
0.28 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
900 |
0.22 |
Functional ≤ 10μM |
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
9700 |
0.18 |
Functional ≤ 10μM
|
Z80214-2-O |
M14 (Melanoma Cells) (cluster #2 Of 3), Other |
Other |
820 |
0.22 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
920 |
0.22 |
Functional ≤ 10μM
|
Z80227-1-O |
MCF7-ADR (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM
|
Z80240-1-O |
MDA-MB-361 (cluster #1 Of 1), Other |
Other |
33 |
0.27 |
Functional ≤ 10μM
|
Z80243-1-O |
MDA-MB-453 (Breast Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
120 |
0.25 |
Functional ≤ 10μM
|
Z80244-4-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #4 Of 7), Other |
Other |
7 |
0.29 |
Functional ≤ 10μM
|
Z80254-1-O |
MES-SA (Uterine Sarcoma Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80255-2-O |
MES-SA/DxS (Uterine Sarcoma Cells) (cluster #2 Of 2), Other |
Other |
704 |
0.22 |
Functional ≤ 10μM
|
Z80267-1-O |
MKN-1 (cluster #1 Of 1), Other |
Other |
640 |
0.22 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
3130 |
0.20 |
Functional ≤ 10μM
|
Z80285-2-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z80295-6-O |
MT4 (Lymphocytes) (cluster #6 Of 8), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80322-2-O |
NCI-H358 (Lung Carcinama Cells) (cluster #2 Of 2), Other |
Other |
620 |
0.22 |
Functional ≤ 10μM
|
Z80330-1-O |
NCI-N87 (cluster #1 Of 1), Other |
Other |
420 |
0.23 |
Functional ≤ 10μM
|
Z80354-4-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #4 Of 4), Other |
Other |
35 |
0.27 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
830 |
0.22 |
Functional ≤ 10μM |
Z80364-1-O |
P388/ADR (Lymphoma Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80367-1-O |
P388/S (cluster #1 Of 1), Other |
Other |
13 |
0.28 |
Functional ≤ 10μM
|
Z80389-1-O |
PC-14 (cluster #1 Of 1), Other |
Other |
290 |
0.23 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
912 |
0.22 |
Functional ≤ 10μM
|
Z80414-1-O |
Raji (B-lymphoblastic Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80433-1-O |
RPMI-8226 (Multiple Myeloma Cells) (cluster #1 Of 3), Other |
Other |
560 |
0.22 |
Functional ≤ 10μM
|
Z80441-1-O |
RXF 944 (cluster #1 Of 1), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80466-1-O |
SF268 (cluster #1 Of 4), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z80468-1-O |
SF-295 (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
35 |
0.27 |
Functional ≤ 10μM
|
Z80472-1-O |
SiHa (Cervical Squamous Cell Carcinoma) (cluster #1 Of 2), Other |
Other |
500 |
0.23 |
Functional ≤ 10μM
|
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80477-1-O |
SK_HEP1 (Hepatoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z80479-1-O |
SK-MEL (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
1730 |
0.21 |
Functional ≤ 10μM
|
Z80481-1-O |
SK-MEL-1 (Metastatic Melanoma Cells) (cluster #1 Of 1), Other |
Other |
3092 |
0.20 |
Functional ≤ 10μM |
Z80482-3-O |
SK-MEL-2 (Melanoma Cells) (cluster #3 Of 4), Other |
Other |
97 |
0.25 |
Functional ≤ 10μM
|
Z80485-1-O |
SK-MEL-28 (Melanoma Cells) (cluster #1 Of 6), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z80490-3-O |
SK-MES-1 (cluster #3 Of 4), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80491-2-O |
SK-N-MC (Neuroepithelioma Cells) (cluster #2 Of 4), Other |
Other |
120 |
0.25 |
Functional ≤ 10μM
|
Z80492-1-O |
SK-N-SH (Neuroblastoma Cells) (cluster #1 Of 2), Other |
Other |
1100 |
0.21 |
Functional ≤ 10μM
|
Z80493-1-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
800 |
0.22 |
Functional ≤ 10μM
|
Z80495-1-O |
SK-VLB (cluster #1 Of 1), Other |
Other |
6540 |
0.19 |
Functional ≤ 10μM
|
Z80503-1-O |
SNU1 (cluster #1 Of 2), Other |
Other |
4000 |
0.19 |
Functional ≤ 10μM
|
Z80509-1-O |
SNU-638 (Gastric Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
690 |
0.22 |
Functional ≤ 10μM
|
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM |
Z80532-1-O |
T-24 (Bladder Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
640 |
0.22 |
Functional ≤ 10μM
|
Z80559-1-O |
U251 (cluster #1 Of 3), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80560-1-O |
U-251 (Glioma Cells) (cluster #1 Of 3), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80563-1-O |
U-373 MG ( Glioblastoma Cells) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80565-1-O |
U-87 MG (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80574-2-O |
UMUC3 (cluster #2 Of 2), Other |
Other |
9 |
0.29 |
Functional ≤ 10μM
|
Z80581-1-O |
VA13 (cluster #1 Of 1), Other |
Other |
699 |
0.22 |
Functional ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 7), Other |
Other |
5000 |
0.19 |
Functional ≤ 10μM
|
Z80595-1-O |
WIL2-NS (Lymphoblastoid Cells) (cluster #1 Of 2), Other |
Other |
200 |
0.24 |
Functional ≤ 10μM |
Z80600-2-O |
XF498 (Glioma Cells) (cluster #2 Of 2), Other |
Other |
44 |
0.26 |
Functional ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
9 |
0.29 |
Functional ≤ 10μM
|
Z80661-1-O |
A704 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2000 |
0.20 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
970 |
0.22 |
Functional ≤ 10μM
|
Z80697-1-O |
Bel-7402 (Hepatoma Cells) (cluster #1 Of 3), Other |
Other |
1000 |
0.22 |
Functional ≤ 10μM
|
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
72 |
0.26 |
Functional ≤ 10μM
|
Z80726-1-O |
TRAMP-C1A (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
76 |
0.26 |
Functional ≤ 10μM
|
Z80730-1-O |
C2D Cell Line (cluster #1 Of 1), Other |
Other |
47 |
0.26 |
Functional ≤ 10μM
|
Z80731-1-O |
C2G Cell Line (cluster #1 Of 1), Other |
Other |
29 |
0.27 |
Functional ≤ 10μM
|
Z80732-1-O |
TRAMP-C2H (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80735-1-O |
C38 (Colon Carcinoma) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80768-1-O |
CH1 (Ovarian Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
6 |
0.30 |
Functional ≤ 10μM
|
Z80784-1-O |
Col2 (Colon Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
520 |
0.23 |
Functional ≤ 10μM
|
Z80801-2-O |
CRL-7065 Cell Line (cluster #2 Of 2), Other |
Other |
500 |
0.23 |
Functional ≤ 10μM
|
Z80819-1-O |
J774.2 (cluster #1 Of 1), Other |
Other |
368 |
0.23 |
Functional ≤ 10μM |
Z80846-1-O |
F460pv8/eto Cell Line (cluster #1 Of 2), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80852-1-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80887-1-O |
H2981 Cell Line (cluster #1 Of 1), Other |
Other |
700 |
0.22 |
Functional ≤ 10μM
|
Z80889-1-O |
NCI-H322M (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80896-1-O |
NCI-H69 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
27 |
0.27 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80936-1-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #1 Of 4), Other |
Other |
900 |
0.22 |
Functional ≤ 10μM |
Z80943-1-O |
HEL 299 (cluster #1 Of 1), Other |
Other |
1700 |
0.21 |
Functional ≤ 10μM |
Z80945-1-O |
HEp-2 (Laryngeal Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
59 |
0.26 |
Functional ≤ 10μM
|
Z81005-1-O |
HTB-54 Cell Line (cluster #1 Of 1), Other |
Other |
1100 |
0.21 |
Functional ≤ 10μM
|
Z81006-1-O |
Human Breast 401NL Tumor Cell Line (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z81017-1-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
620 |
0.22 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
954 |
0.22 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
660 |
0.22 |
Functional ≤ 10μM
|
Z81025-1-O |
Human Lung LXF 529L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z81026-1-O |
Human Lung LXF 629L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z81028-1-O |
Human Melanoma Cell Line (cluster #1 Of 1), Other |
Other |
280 |
0.24 |
Functional ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 10), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z81043-1-O |
N592 (cluster #1 Of 2), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81054-1-O |
SF-268 (Glioblastoma Cells) (cluster #1 Of 3), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z81101-1-O |
KBM-3 Cell Line (cluster #1 Of 1), Other |
Other |
26 |
0.27 |
Functional ≤ 10μM
|
Z81102-1-O |
KBM-3/DOX Cell Line (cluster #1 Of 1), Other |
Other |
490 |
0.23 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
7010 |
0.19 |
Functional ≤ 10μM
|
Z81133-1-O |
L1210 (1565) (cluster #1 Of 1), Other |
Other |
315 |
0.23 |
Functional ≤ 10μM |
Z81134-1-O |
L2987 (Lung Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z81160-1-O |
Lewis Lung Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81164-1-O |
LL Cell Line (cluster #1 Of 2), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81167-1-O |
LLTC Cell Line (cluster #1 Of 1), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
78 |
0.26 |
Functional ≤ 10μM
|
Z81184-1-O |
LOX IMVI (Melanoma Cells) (cluster #1 Of 5), Other |
Other |
42 |
0.26 |
Functional ≤ 10μM
|
Z81201-1-O |
HOP-62 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
4 |
0.30 |
Functional ≤ 10μM
|
Z81211-1-O |
LXFL529 Cell Line (cluster #1 Of 1), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 1), Other |
Other |
79 |
0.25 |
Functional ≤ 10μM |
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
960 |
0.22 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
730 |
0.22 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z81257-1-O |
MEL-AC Cell Line (cluster #1 Of 1), Other |
Other |
1200 |
0.21 |
Functional ≤ 10μM
|
Z81261-1-O |
UACC-375 (cluster #1 Of 1), Other |
Other |
112 |
0.25 |
Functional ≤ 10μM
|
Z81277-2-O |
NCI-N417 (cluster #2 Of 2), Other |
Other |
230 |
0.24 |
Functional ≤ 10μM
|
Z81280-1-O |
NCI-H226 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
8 |
0.29 |
Functional ≤ 10μM
|
Z81284-1-O |
NCI-H647 (cluster #1 Of 2), Other |
Other |
1 |
0.32 |
Functional ≤ 10μM
|
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
80 |
0.25 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
820 |
0.22 |
Functional ≤ 10μM
|
Z81341-1-O |
Tumor Cell Lines (cluster #1 Of 1), Other |
Other |
74 |
0.26 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 2), Other |
Other |
500 |
0.23 |
ADME/T ≤ 10μM
|
Z80002-1-O |
1A9 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
100 |
0.25 |
ADME/T ≤ 10μM
|
Z80005-1-O |
3T3 (Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
3700 |
0.19 |
ADME/T ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.25 |
ADME/T ≤ 10μM
|
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
600 |
0.22 |
ADME/T ≤ 10μM |
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 2), Other |
Other |
60 |
0.26 |
ADME/T ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
480 |
0.23 |
ADME/T ≤ 10μM
|
Z80178-2-O |
J774.A1 (Macrophage Cells) (cluster #2 Of 2), Other |
Other |
20 |
0.28 |
ADME/T ≤ 10μM |
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 3), Other |
Other |
60 |
0.26 |
ADME/T ≤ 10μM
|
Z80193-3-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #3 Of 4), Other |
Other |
29 |
0.27 |
ADME/T ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
33 |
0.27 |
ADME/T ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
70 |
0.26 |
ADME/T ≤ 10μM
|
Z80253-2-O |
MEF (Embryonic Fibroblast Cells) (cluster #2 Of 2), Other |
Other |
3400 |
0.20 |
ADME/T ≤ 10μM
|
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
300 |
0.23 |
ADME/T ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
2000 |
0.20 |
ADME/T ≤ 10μM
|
Z80548-2-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
8 |
0.29 |
ADME/T ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 3), Other |
Other |
7400 |
0.18 |
ADME/T ≤ 10μM
|
Z80682-2-O |
A549 (Lung Carcinoma Cells) (cluster #2 Of 3), Other |
Other |
900 |
0.22 |
ADME/T ≤ 10μM
|
Z80704-1-O |
BJ (Foreskin Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
2700 |
0.20 |
ADME/T ≤ 10μM
|
Z80936-4-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #4 Of 4), Other |
Other |
64 |
0.26 |
ADME/T ≤ 10μM
|
Z81020-1-O |
HepG2 (Hepatoblastoma Cells) (cluster #1 Of 1), Other |
Other |
420 |
0.23 |
ADME/T ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
ADME/T ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
7 |
0.29 |
ADME/T ≤ 10μM
|
Z81057-5-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #5 Of 5), Other |
Other |
30 |
0.27 |
ADME/T ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 3), Other |
Other |
400 |
0.23 |
ADME/T ≤ 10μM
|
Z81331-2-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #2 Of 2), Other |
Other |
178 |
0.24 |
ADME/T ≤ 10μM
|
Q7ZJM1-1-V |
Human Immunodeficiency Virus Type 1 Integrase (cluster #1 Of 6), Viral |
Viruses |
900 |
0.22 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.57 |
-0.9 |
-63.19 |
8 |
12 |
1 |
208 |
544.533 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z50587-5-O |
Homo Sapiens (cluster #5 Of 9), Other |
Other |
500 |
0.37 |
Functional ≤ 10μM
|
Z80017-1-O |
A2780cisR (Cisplatin-resistant Ovarian Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
60 |
0.42 |
Functional ≤ 10μM
|
Z80055-1-O |
CAKI-1 (Kidney Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
40 |
0.43 |
Functional ≤ 10μM
|
Z80089-1-O |
CHO-AA8 (cluster #1 Of 2), Other |
Other |
1 |
0.53 |
Functional ≤ 10μM
|
Z80114-1-O |
Daudi (Burkitts Lymphoma Cells) (cluster #1 Of 4), Other |
Other |
450 |
0.37 |
Functional ≤ 10μM
|
Z80115-1-O |
DC3F (cluster #1 Of 1), Other |
Other |
82 |
0.41 |
Functional ≤ 10μM
|
Z80117-1-O |
DC3F/AD-II (cluster #1 Of 2), Other |
Other |
110 |
0.41 |
Functional ≤ 10μM
|
Z80125-8-O |
DU-145 (Prostate Carcinoma) (cluster #8 Of 9), Other |
Other |
170 |
0.39 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
50 |
0.43 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
99 |
0.41 |
Functional ≤ 10μM |
Z80186-4-O |
K562 (Erythroleukemia Cells) (cluster #4 Of 11), Other |
Other |
470 |
0.37 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
90 |
0.41 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
960 |
0.35 |
Functional ≤ 10μM
|
Z80244-3-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #3 Of 7), Other |
Other |
270 |
0.38 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
51 |
0.43 |
Functional ≤ 10μM
|
Z80364-1-O |
P388/ADR (Lymphoma Cells) (cluster #1 Of 1), Other |
Other |
535 |
0.37 |
Functional ≤ 10μM
|
Z80367-1-O |
P388/S (cluster #1 Of 1), Other |
Other |
48 |
0.43 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
1500 |
0.34 |
Functional ≤ 10μM
|
Z80433-1-O |
RPMI-8226 (Multiple Myeloma Cells) (cluster #1 Of 3), Other |
Other |
200 |
0.39 |
Functional ≤ 10μM
|
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
993 |
0.35 |
Functional ≤ 10μM
|
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
200 |
0.39 |
Functional ≤ 10μM
|
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
7 |
0.48 |
Functional ≤ 10μM
|
Z80647-1-O |
833K Cell Line (cluster #1 Of 1), Other |
Other |
328 |
0.38 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
4500 |
0.31 |
Functional ≤ 10μM
|
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
400 |
0.37 |
Functional ≤ 10μM
|
Z80768-1-O |
CH1 (Ovarian Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
40 |
0.43 |
Functional ≤ 10μM
|
Z80776-1-O |
Clone 62 Cell Line (cluster #1 Of 1), Other |
Other |
1500 |
0.34 |
Functional ≤ 10μM
|
Z80888-1-O |
H2987 Cell Line (cluster #1 Of 1), Other |
Other |
1600 |
0.34 |
Functional ≤ 10μM
|
Z80951-1-O |
NIH3T3 (Fibroblasts) (cluster #1 Of 4), Other |
Other |
1700 |
0.34 |
Functional ≤ 10μM
|
Z81017-1-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
10 |
0.47 |
Functional ≤ 10μM
|
Z81020-2-O |
HepG2 (Hepatoblastoma Cells) (cluster #2 Of 8), Other |
Other |
5400 |
0.31 |
Functional ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 10), Other |
Other |
50 |
0.43 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
600 |
0.36 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
810 |
0.36 |
Functional ≤ 10μM
|
Z81264-1-O |
V79 (Lung Fibroblasts) (cluster #1 Of 2), Other |
Other |
800 |
0.36 |
Functional ≤ 10μM
|
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
70 |
0.42 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 2), Other |
Other |
4030 |
0.31 |
ADME/T ≤ 10μM
|
Z81264-1-O |
V79 (Lung Fibroblasts) (cluster #1 Of 2), Other |
Other |
400 |
0.37 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-1.23 |
-4.19 |
-10.5 |
4 |
9 |
0 |
145 |
334.332 |
4 |
↓
|
Mid
Mid (pH 6-8)
|
-1.23 |
-4.19 |
-11.87 |
4 |
9 |
0 |
145 |
334.332 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CCNA2-1-E |
Cyclin A2 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
355 |
0.27 |
Binding ≤ 10μM
|
CDK2-1-E |
Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
355 |
0.27 |
Binding ≤ 10μM
|
KIT-1-E |
Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1904 |
0.24 |
Binding ≤ 10μM
|
PLK1-1-E |
Serine/threonine-protein Kinase PLK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7 |
0.35 |
Binding ≤ 10μM
|
PLK2-1-E |
Serine/threonine-protein Kinase PLK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
238 |
0.28 |
Binding ≤ 10μM
|
PLK3-1-E |
Serine/threonine-protein Kinase PLK3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
450 |
0.27 |
Binding ≤ 10μM
|
VGFR3-1-E |
Vascular Endothelial Growth Factor Receptor 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
587 |
0.26 |
Binding ≤ 10μM
|
Z104294-1-O |
Cyclin-dependent Kinase 5/CDK5 Activator 1 (cluster #1 Of 2), Other |
Other |
219 |
0.28 |
Binding ≤ 10μM
|
Z104296-1-O |
Cyclin-dependent Kinase 1/cyclin B1 (cluster #1 Of 2), Other |
Other |
160 |
0.29 |
Binding ≤ 10μM
|
Z104299-1-O |
Cyclin-dependent Kinase 2/cyclin E1 (cluster #1 Of 1), Other |
Other |
347 |
0.27 |
Binding ≤ 10μM
|
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
10 |
0.34 |
Functional ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
78 |
0.30 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
44 |
0.31 |
Functional ≤ 10μM
|
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
25 |
0.32 |
Functional ≤ 10μM
|
Z80942-1-O |
HEL (Embryonic Lung Cells) (cluster #1 Of 2), Other |
Other |
5 |
0.35 |
Functional ≤ 10μM
|
Z81034-1-O |
A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
9 |
0.34 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
8 |
0.34 |
Functional ≤ 10μM
|
Z80335-1-O |
NHDF (cluster #1 Of 2), Other |
Other |
73 |
0.30 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.49 |
7.93 |
-49.42 |
4 |
10 |
1 |
116 |
449.539 |
5 |
↓
|
|
|
Analogs
-
9805467
-
-
9805468
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80354-1-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
3350 |
0.21 |
Functional ≤ 10μM
|
Z81034-1-O |
A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
7940 |
0.20 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
6.67 |
1.02 |
-56.92 |
0 |
6 |
-1 |
83 |
493.564 |
4 |
↓
|
|
|
Analogs
-
9805467
-
-
9805468
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80354-1-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
3350 |
0.21 |
Functional ≤ 10μM
|
Z81034-1-O |
A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
7940 |
0.20 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
6.67 |
0.92 |
-57.17 |
0 |
6 |
-1 |
83 |
493.564 |
4 |
↓
|
|
|
Analogs
-
39049630
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80186-5-O |
K562 (Erythroleukemia Cells) (cluster #5 Of 11), Other |
Other |
2000 |
0.80 |
Functional ≤ 10μM
|
Z81034-1-O |
A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
3100 |
0.77 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.62 |
5.61 |
-11.27 |
0 |
2 |
0 |
30 |
134.134 |
0 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
KIF11-1-E |
Kinesin-like Protein 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
53 |
0.27 |
Binding ≤ 10μM |
Z80026-1-O |
AGS (Gastric Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM |
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
3330 |
0.20 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
7020 |
0.19 |
Functional ≤ 10μM
|
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
940 |
0.22 |
Functional ≤ 10μM
|
Z81020-7-O |
HepG2 (Hepatoblastoma Cells) (cluster #7 Of 8), Other |
Other |
2100 |
0.21 |
Functional ≤ 10μM
|
Z81034-3-O |
A2780 (Ovarian Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
3000 |
0.20 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.94 |
2.26 |
-55.93 |
1 |
6 |
1 |
59 |
596.977 |
10 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
KIF11-1-E |
Kinesin-like Protein 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
12 |
0.29 |
Binding ≤ 10μM
|
KIF11-1-E |
Kinesin-like Protein 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
53 |
0.27 |
Binding ≤ 10μM |
Z80026-1-O |
AGS (Gastric Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM |
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
3330 |
0.20 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
7020 |
0.19 |
Functional ≤ 10μM
|
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
940 |
0.22 |
Functional ≤ 10μM
|
Z81020-7-O |
HepG2 (Hepatoblastoma Cells) (cluster #7 Of 8), Other |
Other |
2100 |
0.21 |
Functional ≤ 10μM
|
Z81034-3-O |
A2780 (Ovarian Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
3000 |
0.20 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.94 |
17.46 |
-55.26 |
1 |
6 |
1 |
60 |
596.977 |
10 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.01 |
7.99 |
-52.68 |
3 |
7 |
1 |
83 |
362.498 |
4 |
↓
|
Ref
Reference (pH 7)
|
2.19 |
6.32 |
-43.89 |
3 |
7 |
1 |
86 |
362.498 |
4 |
↓
|
Hi
High (pH 8-9.5)
|
1.64 |
5.69 |
-104.44 |
8 |
9 |
2 |
142 |
511.577 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.05 |
-1.59 |
-15.91 |
1 |
7 |
0 |
98 |
376.368 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.27 |
-0.66 |
-50.22 |
2 |
4 |
1 |
46 |
328.823 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MTOR-2-E |
Serine/threonine-protein Kinase MTOR (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
4000 |
0.27 |
Binding ≤ 10μM |
PI4KB-1-E |
PI4-kinase Beta Subunit (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
5000 |
0.27 |
Binding ≤ 10μM |
PK3CA-2-E |
PI3-kinase P110-alpha Subunit (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
90 |
0.35 |
Binding ≤ 10μM |
PK3CB-2-E |
PI3-kinase P110-beta Subunit (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
92 |
0.35 |
Binding ≤ 10μM |
PK3CD-2-E |
PI3-kinase P110-delta Subunit (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
20 |
0.38 |
Binding ≤ 10μM |
PK3CG-2-E |
PI3-kinase P110-gamma Subunit (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
9 |
0.40 |
Binding ≤ 10μM |
Z81034-1-O |
A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
730 |
0.31 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.18 |
6.37 |
-11.32 |
3 |
10 |
0 |
124 |
380.412 |
5 |
↓
|
Mid
Mid (pH 6-8)
|
2.18 |
6.63 |
-36.84 |
4 |
10 |
1 |
125 |
381.42 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80285-3-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #3 Of 4), Other |
Other |
420 |
0.33 |
Functional ≤ 10μM |
Z80463-1-O |
SCOV-3 (cluster #1 Of 1), Other |
Other |
2150 |
0.29 |
Functional ≤ 10μM |
Z80586-1-O |
WEHI (Macrophages) (cluster #1 Of 1), Other |
Other |
300 |
0.34 |
Functional ≤ 10μM |
Z80972-1-O |
HOP-92 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
360 |
0.33 |
Functional ≤ 10μM |
Z81034-1-O |
A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
760 |
0.32 |
Functional ≤ 10μM |
Z81240-1-O |
MAC15A (Colon Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
500 |
0.33 |
Functional ≤ 10μM |
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
1440 |
0.30 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.99 |
9.49 |
-51.2 |
2 |
6 |
1 |
68 |
381.481 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
7080 |
0.25 |
Functional ≤ 10μM |
Z80285-3-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #3 Of 4), Other |
Other |
3300 |
0.26 |
Functional ≤ 10μM |
Z81034-1-O |
A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
7600 |
0.25 |
Functional ≤ 10μM |
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
4850 |
0.26 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.56 |
5.88 |
-21.38 |
1 |
7 |
0 |
76 |
408.483 |
4 |
↓
|
|
|
Analogs
-
16889837
-
-
6920405
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CDK1-2-E |
Cyclin-dependent Kinase 1 (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
150 |
0.28 |
Binding ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 10), Other |
Other |
60 |
0.30 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-4.90 |
-22.23 |
-17.5 |
11 |
16 |
0 |
269 |
504.438 |
8 |
↓
|
|
|
Analogs
-
1736679
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 33 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z81034-3-O |
A2780 (Ovarian Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
8000 |
0.71 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.90 |
2.32 |
-1.68 |
0 |
0 |
0 |
0 |
134.222 |
1 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 30 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z81034-3-O |
A2780 (Ovarian Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
6000 |
0.61 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.73 |
7.9 |
-3.48 |
0 |
0 |
0 |
0 |
154.212 |
1 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
2 |
0.45 |
Functional ≤ 10μM |
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
19 |
0.40 |
Functional ≤ 10μM |
Z103208-1-O |
AU565 (cluster #1 Of 1), Other |
Other |
6 |
0.43 |
Functional ≤ 10μM |
Z80125-9-O |
DU-145 (Prostate Carcinoma) (cluster #9 Of 9), Other |
Other |
0 |
0.00 |
Functional ≤ 10μM |
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
0 |
0.00 |
Functional ≤ 10μM |
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
2 |
0.45 |
Functional ≤ 10μM |
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
1 |
0.47 |
Functional ≤ 10μM |
Z80640-1-O |
786-0 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
1 |
0.47 |
Functional ≤ 10μM |
Z81034-1-O |
A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
0 |
0.00 |
Functional ≤ 10μM |
Z81057-1-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #1 Of 4), Other |
Other |
25 |
0.39 |
Functional ≤ 10μM |
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
1 |
0.47 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.04 |
5.12 |
-14.92 |
1 |
7 |
0 |
87 |
372.373 |
6 |
↓
|
Hi
High (pH 8-9.5)
|
3.04 |
6.04 |
-56.69 |
0 |
7 |
-1 |
90 |
371.365 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 2 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
HDA10-1-E |
Histone Deacetylase 10 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
23 |
0.41 |
Binding ≤ 10μM |
HDA11-1-E |
Histone Deacetylase 11 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
24 |
0.41 |
Binding ≤ 10μM |
HDAC1-2-E |
Histone Deacetylase 1 (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
77 |
0.38 |
Binding ≤ 10μM |
HDAC2-1-E |
Histone Deacetylase 2 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
27 |
0.41 |
Binding ≤ 10μM |
HDAC3-1-E |
Histone Deacetylase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
19 |
0.42 |
Binding ≤ 10μM |
HDAC4-1-E |
Histone Deacetylase 4 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
16 |
0.42 |
Binding ≤ 10μM |
HDAC5-1-E |
Histone Deacetylase 5 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
21 |
0.41 |
Binding ≤ 10μM |
HDAC6-1-E |
Histone Deacetylase 6 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
247 |
0.36 |
Binding ≤ 10μM |
HDAC7-1-E |
Histone Deacetylase 7 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
104 |
0.38 |
Binding ≤ 10μM |
HDAC8-1-E |
Histone Deacetylase 8 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
48 |
0.39 |
Binding ≤ 10μM |
HDAC9-1-E |
Histone Deacetylase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
24 |
0.41 |
Binding ≤ 10μM |
CP2CJ-1-E |
Cytochrome P450 2C19 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
5780 |
0.28 |
ADME/T ≤ 10μM |
CP3A4-2-E |
Cytochrome P450 3A4 (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
2730 |
0.30 |
ADME/T ≤ 10μM |
Z100405-1-O |
MV4-11 (Myeloid Leukemia Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.38 |
Functional ≤ 10μM |
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
340 |
0.35 |
Functional ≤ 10μM |
Z80415-1-O |
Ramos (Burkitts Lymhoma B-cells) (cluster #1 Of 1), Other |
Other |
140 |
0.37 |
Functional ≤ 10μM |
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
480 |
0.34 |
Functional ≤ 10μM |
Z81034-6-O |
A2780 (Ovarian Carcinoma Cells) (cluster #6 Of 10), Other |
Other |
480 |
0.34 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.49 |
9.6 |
-62.75 |
3 |
6 |
1 |
72 |
359.494 |
10 |
↓
|
Hi
High (pH 8-9.5)
|
3.49 |
7.49 |
-18.21 |
2 |
6 |
0 |
70 |
358.486 |
10 |
↓
|
Lo
Low (pH 4.5-6)
|
3.49 |
9.9 |
-112.62 |
4 |
6 |
2 |
73 |
360.502 |
10 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 75 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
TYSY-3-E |
Thymidylate Synthase (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
7000 |
0.80 |
Binding ≤ 10μM
|
Z103205-4-O |
A431 (cluster #4 Of 4), Other |
Other |
18 |
1.20 |
Functional ≤ 10μM
|
Z103419-1-O |
UACC-812 (cluster #1 Of 2), Other |
Other |
3100 |
0.86 |
Functional ≤ 10μM
|
Z50425-14-O |
Plasmodium Falciparum (cluster #14 Of 22), Other |
Other |
7943 |
0.79 |
Functional ≤ 10μM
|
Z80035-6-O |
B16 (Melanoma Cells) (cluster #6 Of 7), Other |
Other |
8730 |
0.79 |
Functional ≤ 10μM
|
Z80054-2-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #2 Of 4), Other |
Other |
1500 |
0.91 |
Functional ≤ 10μM
|
Z80064-6-O |
CCRF-CEM (T-cell Leukemia) (cluster #6 Of 9), Other |
Other |
5000 |
0.82 |
Functional ≤ 10μM
|
Z80088-4-O |
CHO (Ovarian Cells) (cluster #4 Of 4), Other |
Other |
5000 |
0.82 |
Functional ≤ 10μM
|
Z80101-1-O |
COLO 320DM (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
1100 |
0.93 |
Functional ≤ 10μM |
Z80120-3-O |
DLD-1 (Colon Adenocarcinoma Cells) (cluster #3 Of 5), Other |
Other |
6000 |
0.81 |
Functional ≤ 10μM |
Z80125-6-O |
DU-145 (Prostate Carcinoma) (cluster #6 Of 9), Other |
Other |
4800 |
0.83 |
Functional ≤ 10μM
|
Z80136-3-O |
FM3A (Breast Carcinoma Cells) (cluster #3 Of 6), Other |
Other |
180 |
1.05 |
Functional ≤ 10μM
|
Z80156-6-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #6 Of 12), Other |
Other |
9500 |
0.78 |
Functional ≤ 10μM
|
Z80164-4-O |
HT-1080 (Fibrosarcoma Cells) (cluster #4 Of 6), Other |
Other |
9450 |
0.78 |
Functional ≤ 10μM
|
Z80166-8-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #8 Of 12), Other |
Other |
7300 |
0.80 |
Functional ≤ 10μM
|
Z80186-7-O |
K562 (Erythroleukemia Cells) (cluster #7 Of 11), Other |
Other |
2400 |
0.87 |
Functional ≤ 10μM
|
Z80192-2-O |
KM12 (Colon Adenocarcinoma Cells) (cluster #2 Of 4), Other |
Other |
8320 |
0.79 |
Functional ≤ 10μM
|
Z80193-8-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #8 Of 12), Other |
Other |
970 |
0.94 |
Functional ≤ 10μM
|
Z80224-5-O |
MCF7 (Breast Carcinoma Cells) (cluster #5 Of 14), Other |
Other |
9600 |
0.78 |
Functional ≤ 10μM
|
Z80268-1-O |
MKN-28 (Gastric Epithelial Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
2500 |
0.87 |
Functional ≤ 10μM |
Z80269-3-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #3 Of 3), Other |
Other |
3000 |
0.86 |
Functional ≤ 10μM |
Z80347-2-O |
NUGC-3 (Gastric Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
4400 |
0.83 |
Functional ≤ 10μM |
Z80362-5-O |
P388 (Lymphoma Cells) (cluster #5 Of 8), Other |
Other |
609 |
0.97 |
Functional ≤ 10μM |
Z80390-6-O |
PC-3 (Prostate Carcinoma Cells) (cluster #6 Of 10), Other |
Other |
16 |
1.21 |
Functional ≤ 10μM
|
Z80485-4-O |
SK-MEL-28 (Melanoma Cells) (cluster #4 Of 6), Other |
Other |
4500 |
0.83 |
Functional ≤ 10μM
|
Z80490-4-O |
SK-MES-1 (cluster #4 Of 4), Other |
Other |
310 |
1.01 |
Functional ≤ 10μM
|
Z80525-2-O |
SW48 (cluster #2 Of 2), Other |
Other |
5700 |
0.82 |
Functional ≤ 10μM |
Z80526-3-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #3 Of 6), Other |
Other |
8100 |
0.79 |
Functional ≤ 10μM
|
Z80532-5-O |
T-24 (Bladder Carcinoma Cells) (cluster #5 Of 6), Other |
Other |
4100 |
0.84 |
Functional ≤ 10μM
|
Z80583-6-O |
Vero (Kidney Cells) (cluster #6 Of 7), Other |
Other |
6810 |
0.80 |
Functional ≤ 10μM
|
Z80641-1-O |
791T Cell Line (cluster #1 Of 1), Other |
Other |
5500 |
0.82 |
Functional ≤ 10μM
|
Z80653-2-O |
9L (Glioma Cells) (cluster #2 Of 2), Other |
Other |
1000 |
0.93 |
Functional ≤ 10μM
|
Z80682-9-O |
A549 (Lung Carcinoma Cells) (cluster #9 Of 11), Other |
Other |
9200 |
0.78 |
Functional ≤ 10μM
|
Z80686-1-O |
AZ-521 Cell Line (cluster #1 Of 1), Other |
Other |
3900 |
0.84 |
Functional ≤ 10μM |
Z80712-5-O |
T47D (Breast Carcinoma Cells) (cluster #5 Of 7), Other |
Other |
600 |
0.97 |
Functional ≤ 10μM
|
Z80724-1-O |
C170 Cell Line (cluster #1 Of 1), Other |
Other |
2000 |
0.89 |
Functional ≤ 10μM
|
Z80742-2-O |
C6 (Glioma Cells) (cluster #2 Of 3), Other |
Other |
6100 |
0.81 |
Functional ≤ 10μM
|
Z80874-5-O |
CEM (T-cell Leukemia) (cluster #5 Of 7), Other |
Other |
9230 |
0.78 |
Functional ≤ 10μM
|
Z80928-7-O |
HCT-116 (Colon Carcinoma Cells) (cluster #7 Of 9), Other |
Other |
8510 |
0.79 |
Functional ≤ 10μM
|
Z81020-1-O |
HepG2 (Hepatoblastoma Cells) (cluster #1 Of 8), Other |
Other |
9200 |
0.78 |
Functional ≤ 10μM
|
Z81024-6-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #6 Of 8), Other |
Other |
8500 |
0.79 |
Functional ≤ 10μM |
Z81034-5-O |
A2780 (Ovarian Carcinoma Cells) (cluster #5 Of 10), Other |
Other |
7210 |
0.80 |
Functional ≤ 10μM
|
Z81041-1-O |
Prostatic Carcinoma Cells (cluster #1 Of 2), Other |
Other |
6400 |
0.81 |
Functional ≤ 10μM
|
Z81043-2-O |
N592 (cluster #2 Of 2), Other |
Other |
5400 |
0.82 |
Functional ≤ 10μM
|
Z81048-1-O |
TSU (Prostatic Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
3600 |
0.85 |
Functional ≤ 10μM
|
Z81115-6-O |
KB (Squamous Cell Carcinoma) (cluster #6 Of 6), Other |
Other |
4460 |
0.83 |
Functional ≤ 10μM
|
Z81121-1-O |
KKLS Cell Line (cluster #1 Of 1), Other |
Other |
6200 |
0.81 |
Functional ≤ 10μM |
Z81170-4-O |
LNCaP (Prostate Carcinoma) (cluster #4 Of 5), Other |
Other |
4900 |
0.83 |
Functional ≤ 10μM
|
Z81247-7-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #7 Of 9), Other |
Other |
9700 |
0.78 |
Functional ≤ 10μM
|
Z81252-9-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #9 Of 11), Other |
Other |
9600 |
0.78 |
Functional ≤ 10μM
|
Z81330-1-O |
SNU- (cluster #1 Of 1), Other |
Other |
2700 |
0.87 |
Functional ≤ 10μM |
Z81331-3-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #3 Of 6), Other |
Other |
9000 |
0.78 |
Functional ≤ 10μM
|
Z81335-3-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #3 Of 5), Other |
Other |
9710 |
0.78 |
Functional ≤ 10μM
|
Z80156-3-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #3 Of 4), Other |
Other |
160 |
1.06 |
ADME/T ≤ 10μM
|
Z80192-2-O |
KM12 (Colon Adenocarcinoma Cells) (cluster #2 Of 2), Other |
Other |
7940 |
0.79 |
ADME/T ≤ 10μM
|
Z80193-4-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #4 Of 4), Other |
Other |
560 |
0.97 |
ADME/T ≤ 10μM
|
Z80583-3-O |
Vero (Kidney Cells) (cluster #3 Of 3), Other |
Other |
200 |
1.04 |
ADME/T ≤ 10μM
|
Z80901-2-O |
HaCaT (Keratinocytes) (cluster #2 Of 2), Other |
Other |
400 |
1.00 |
ADME/T ≤ 10μM
|
Z80928-2-O |
HCT-116 (Colon Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
2040 |
0.89 |
ADME/T ≤ 10μM
|
Z81247-2-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 3), Other |
Other |
570 |
0.97 |
ADME/T ≤ 10μM
|
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 2), Other |
Other |
6610 |
0.81 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-0.59 |
-1.23 |
-13.33 |
2 |
4 |
0 |
66 |
130.078 |
0 |
↓
|
Hi
High (pH 8-9.5)
|
-0.13 |
-4 |
-48.58 |
1 |
4 |
-1 |
69 |
129.07 |
0 |
↓
|
Mid
Mid (pH 6-8)
|
-0.13 |
-3.14 |
-32.57 |
1 |
4 |
-1 |
69 |
129.07 |
0 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CCNA1-1-E |
Cyclin A1 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
37 |
0.42 |
Binding ≤ 10μM
|
CCNA1-1-E |
Cyclin A1 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
169 |
0.38 |
Binding ≤ 10μM
|
CCNA2-1-E |
Cyclin A2 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
37 |
0.42 |
Binding ≤ 10μM
|
CCNA2-1-E |
Cyclin A2 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
169 |
0.38 |
Binding ≤ 10μM
|
CCNB1-2-E |
G2/mitotic-specific Cyclin B1 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
208 |
0.37 |
Binding ≤ 10μM
|
CCNB2-2-E |
G2/mitotic-specific Cyclin B2 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
208 |
0.37 |
Binding ≤ 10μM
|
CCNB3-2-E |
G2/mitotic-specific Cyclin B3 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
208 |
0.37 |
Binding ≤ 10μM
|
CCNE1-2-E |
G1/S-specific Cyclin E1 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
55 |
0.41 |
Binding ≤ 10μM
|
CCNE2-2-E |
G1/S-specific Cyclin E2 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
55 |
0.41 |
Binding ≤ 10μM
|
CDK1-3-E |
Cyclin-dependent Kinase 1 (cluster #3 Of 4), Eukaryotic |
Eukaryotes |
208 |
0.37 |
Binding ≤ 10μM
|
CDK2-2-E |
Cyclin-dependent Kinase 2 (cluster #2 Of 5), Eukaryotic |
Eukaryotes |
55 |
0.41 |
Binding ≤ 10μM
|
CDK2-2-E |
Cyclin-dependent Kinase 2 (cluster #2 Of 5), Eukaryotic |
Eukaryotes |
169 |
0.38 |
Binding ≤ 10μM
|
GSK3B-1-E |
Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic |
Eukaryotes |
732 |
0.34 |
Binding ≤ 10μM
|
Z104294-1-O |
Cyclin-dependent Kinase 5/CDK5 Activator 1 (cluster #1 Of 2), Other |
Other |
65 |
0.40 |
Binding ≤ 10μM
|
Z80166-4-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #4 Of 12), Other |
Other |
639 |
0.35 |
Functional ≤ 10μM
|
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
1354 |
0.33 |
Functional ≤ 10μM
|
Z81034-3-O |
A2780 (Ovarian Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
630 |
0.35 |
Functional ≤ 10μM
|
Z81034-3-O |
A2780 (Ovarian Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
800 |
0.34 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.17 |
8.37 |
-18.97 |
2 |
6 |
0 |
78 |
338.411 |
5 |
↓
|
Ref
Reference (pH 7)
|
2.17 |
8.31 |
-20.43 |
2 |
6 |
0 |
78 |
338.411 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.17 |
8.37 |
-19.4 |
2 |
6 |
0 |
78 |
338.411 |
5 |
↓
|
Ref
Reference (pH 7)
|
2.17 |
8.3 |
-20.65 |
2 |
6 |
0 |
78 |
338.411 |
5 |
↓
|
|
|
Analogs
-
34527023
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Q862F3-2-E |
Tubulin Alpha Chain (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
2200 |
0.30 |
Functional ≤ 10μM
|
Q862L2-2-E |
Tubulin Alpha-1 Chain (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
2200 |
0.30 |
Functional ≤ 10μM
|
TBA1A-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3100 |
0.30 |
Functional ≤ 10μM
|
TBB2B-2-E |
Tubulin Beta Chain (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
2200 |
0.30 |
Functional ≤ 10μM
|
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
1111 |
0.32 |
Functional ≤ 10μM |
Z80125-4-O |
DU-145 (Prostate Carcinoma) (cluster #4 Of 9), Other |
Other |
839 |
0.33 |
Functional ≤ 10μM |
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 12), Other |
Other |
340 |
0.35 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
190 |
0.36 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
786 |
0.33 |
Functional ≤ 10μM |
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
960 |
0.32 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
350 |
0.35 |
Functional ≤ 10μM
|
Z81034-1-O |
A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
170 |
0.36 |
Functional ≤ 10μM |
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
160 |
0.37 |
Functional ≤ 10μM |
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
658 |
0.33 |
Functional ≤ 10μM |
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
270 |
0.35 |
Functional ≤ 10μM |
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
190 |
0.36 |
Functional ≤ 10μM |
Z81335-4-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #4 Of 5), Other |
Other |
340 |
0.35 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.33 |
3.28 |
-12.76 |
3 |
7 |
0 |
101 |
371.418 |
6 |
↓
|
Hi
High (pH 8-9.5)
|
3.33 |
3.22 |
-44.02 |
2 |
7 |
-1 |
103 |
370.41 |
6 |
↓
|
|
|
Analogs
-
2048978
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.62 |
8.42 |
-38.73 |
1 |
4 |
-1 |
77 |
293.383 |
10 |
↓
|
Hi
High (pH 8-9.5)
|
4.62 |
11.56 |
-99.76 |
0 |
4 |
-2 |
80 |
292.375 |
10 |
↓
|
Hi
High (pH 8-9.5)
|
4.62 |
8.33 |
-41.37 |
1 |
4 |
-1 |
77 |
293.383 |
10 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CDC7-1-E |
Cell Division Cycle 7-related Protein Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
10 |
0.70 |
Binding ≤ 10μM
|
CDK1-1-E |
Cyclin-dependent Kinase 1 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
250 |
0.58 |
Binding ≤ 10μM
|
CDK2-1-E |
Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
240 |
0.58 |
Binding ≤ 10μM
|
CDK5-1-E |
Cyclin-dependent Kinase 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
460 |
0.55 |
Binding ≤ 10μM
|
CDK9-1-E |
Cyclin-dependent Kinase 9 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
34 |
0.65 |
Binding ≤ 10μM
|
CHK2-1-E |
Serine/threonine-protein Kinase Chk2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1100 |
0.52 |
Binding ≤ 10μM
|
GSK3B-1-E |
Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic |
Eukaryotes |
220 |
0.58 |
Binding ≤ 10μM
|
KS6A4-1-E |
Ribosomal Protein S6 Kinase Alpha 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3010 |
0.48 |
Binding ≤ 10μM
|
KS6A5-2-E |
Ribosomal Protein S6 Kinase Alpha 5 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
2340 |
0.49 |
Binding ≤ 10μM
|
MAPK2-1-E |
MAP Kinase-activated Protein Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
470 |
0.55 |
Binding ≤ 10μM
|
MAPK5-1-E |
MAP Kinase-activated Protein Kinase 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
500 |
0.55 |
Binding ≤ 10μM
|
MKNK1-1-E |
MAP Kinase-interacting Serine/threonine-protein Kinase MNK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2670 |
0.49 |
Binding ≤ 10μM
|
MKNK2-1-E |
MAP Kinase Signal-integrating Kinase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
171 |
0.59 |
Binding ≤ 10μM
|
PLK1-1-E |
Serine/threonine-protein Kinase PLK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
980 |
0.53 |
Binding ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
5000 |
0.46 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
5870 |
0.46 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
1330 |
0.51 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
4590 |
0.47 |
Functional ≤ 10μM
|
Z80466-1-O |
SF268 (cluster #1 Of 4), Other |
Other |
860 |
0.53 |
Functional ≤ 10μM
|
Z80525-1-O |
SW48 (cluster #1 Of 2), Other |
Other |
1200 |
0.52 |
Functional ≤ 10μM
|
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
2670 |
0.49 |
Functional ≤ 10μM
|
Z80561-1-O |
U2OS (Osteosarcoma Cells) (cluster #1 Of 1), Other |
Other |
1490 |
0.51 |
Functional ≤ 10μM
|
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
970 |
0.53 |
Functional ≤ 10μM
|
Z81034-3-O |
A2780 (Ovarian Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
1100 |
0.52 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
3200 |
0.48 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
1830 |
0.50 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
3810 |
0.47 |
Functional ≤ 10μM
|
Z80335-1-O |
NHDF (cluster #1 Of 2), Other |
Other |
1600 |
0.51 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.64 |
2.58 |
-15.17 |
2 |
4 |
0 |
58 |
213.24 |
1 |
↓
|
Lo
Low (pH 4.5-6)
|
0.64 |
2.88 |
-44.62 |
3 |
4 |
1 |
59 |
214.248 |
1 |
↓
|
|
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.57 |
7.17 |
-10.84 |
1 |
4 |
0 |
45 |
272.739 |
2 |
↓
|
Hi
High (pH 8-9.5)
|
3.57 |
6.75 |
-41.88 |
0 |
4 |
-1 |
43 |
271.731 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
10000 |
0.18 |
Functional ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 10), Other |
Other |
4890 |
0.19 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.81 |
4.44 |
-25.24 |
3 |
10 |
0 |
157 |
542.581 |
5 |
↓
|
|
|
Analogs
-
11677636
-
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.53 |
11.26 |
-67.87 |
6 |
8 |
2 |
101 |
400.49 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 26 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
KPCE-4-E |
Protein Kinase C Epsilon (cluster #4 Of 5), Eukaryotic |
Eukaryotes |
24 |
0.41 |
Binding ≤ 10μM
|
Z81034-6-O |
A2780 (Ovarian Carcinoma Cells) (cluster #6 Of 10), Other |
Other |
4630 |
0.29 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.75 |
9.03 |
-30.15 |
0 |
5 |
1 |
41 |
348.378 |
2 |
↓
|
|
|
Analogs
-
4517652
-
-
4823972
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 35 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
TOP1-1-E |
DNA Topoisomerase 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
110 |
0.36 |
Binding ≤ 10μM
|
Z80099-1-O |
COLO 205 (Colon Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
9 |
0.42 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
410 |
0.33 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
9 |
0.42 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
4100 |
0.28 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
18 |
0.40 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
12 |
0.41 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
110 |
0.36 |
Functional ≤ 10μM
|
Z80697-1-O |
Bel-7402 (Hepatoma Cells) (cluster #1 Of 3), Other |
Other |
280 |
0.34 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
148 |
0.35 |
Functional ≤ 10μM
|
Z81020-7-O |
HepG2 (Hepatoblastoma Cells) (cluster #7 Of 8), Other |
Other |
981 |
0.31 |
Functional ≤ 10μM
|
Z81034-1-O |
A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
700 |
0.32 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
30 |
0.39 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
829 |
0.32 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.53 |
3.91 |
-13.24 |
2 |
7 |
0 |
102 |
364.357 |
1 |
↓
|
Hi
High (pH 8-9.5)
|
2.28 |
3.5 |
-56.32 |
2 |
7 |
0 |
102 |
364.357 |
1 |
↓
|
Hi
High (pH 8-9.5)
|
2.28 |
4.82 |
-55.03 |
2 |
7 |
0 |
104 |
364.357 |
1 |
↓
|
|
|
Analogs
-
5724366
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 14 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.13 |
2.17 |
-9.54 |
2 |
4 |
0 |
75 |
190.154 |
0 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 19 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
HDA10-1-E |
Histone Deacetylase 10 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4800 |
0.27 |
Binding ≤ 10μM
|
HDA11-1-E |
Histone Deacetylase 11 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4800 |
0.27 |
Binding ≤ 10μM
|
HDAC1-1-E |
Histone Deacetylase 1 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
600 |
0.31 |
Binding ≤ 10μM
|
HDAC2-2-E |
Histone Deacetylase 2 (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
65 |
0.36 |
Binding ≤ 10μM
|
HDAC3-1-E |
Histone Deacetylase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
740 |
0.31 |
Binding ≤ 10μM
|
HDAC4-1-E |
Histone Deacetylase 4 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
510 |
0.31 |
Binding ≤ 10μM
|
HDAC5-1-E |
Histone Deacetylase 5 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4800 |
0.27 |
Binding ≤ 10μM
|
HDAC6-1-E |
Histone Deacetylase 6 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4800 |
0.27 |
Binding ≤ 10μM
|
HDAC7-1-E |
Histone Deacetylase 7 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4800 |
0.27 |
Binding ≤ 10μM
|
HDAC8-1-E |
Histone Deacetylase 8 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
4800 |
0.27 |
Binding ≤ 10μM
|
HDAC9-1-E |
Histone Deacetylase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4800 |
0.27 |
Binding ≤ 10μM
|
Q9XYC7-1-E |
Histone Deacetylase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
940 |
0.30 |
Binding ≤ 10μM
|
TF-1-E |
Coagulation Factor III (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6000 |
0.26 |
Binding ≤ 10μM
|
HDA10-1-E |
Histone Deacetylase 10 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1000 |
0.30 |
Functional ≤ 10μM
|
HDA11-1-E |
Histone Deacetylase 11 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1000 |
0.30 |
Functional ≤ 10μM
|
HDAC1-1-E |
Histone Deacetylase 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.30 |
Functional ≤ 10μM
|
HDAC2-1-E |
Histone Deacetylase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.30 |
Functional ≤ 10μM
|
HDAC3-1-E |
Histone Deacetylase 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.30 |
Functional ≤ 10μM
|
HDAC4-1-E |
Histone Deacetylase 4 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.30 |
Functional ≤ 10μM
|
HDAC5-1-E |
Histone Deacetylase 5 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.30 |
Functional ≤ 10μM
|
HDAC6-1-E |
Histone Deacetylase 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1000 |
0.30 |
Functional ≤ 10μM
|
HDAC7-1-E |
Histone Deacetylase 7 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.30 |
Functional ≤ 10μM
|
HDAC8-1-E |
Histone Deacetylase 8 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.30 |
Functional ≤ 10μM
|
HDAC9-1-E |
Histone Deacetylase 9 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.30 |
Functional ≤ 10μM
|
CP3A4-2-E |
Cytochrome P450 3A4 (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
730 |
0.31 |
ADME/T ≤ 10μM |
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
2000 |
0.28 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
5000 |
0.27 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
4160 |
0.27 |
Functional ≤ 10μM
|
Z80475-2-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #2 Of 3), Other |
Other |
870 |
0.30 |
Functional ≤ 10μM
|
Z80525-1-O |
SW48 (cluster #1 Of 2), Other |
Other |
5000 |
0.27 |
Functional ≤ 10μM
|
Z80532-3-O |
T-24 (Bladder Carcinoma Cells) (cluster #3 Of 6), Other |
Other |
2500 |
0.28 |
Functional ≤ 10μM
|
Z80682-2-O |
A549 (Lung Carcinoma Cells) (cluster #2 Of 11), Other |
Other |
8000 |
0.25 |
Functional ≤ 10μM
|
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
800 |
0.30 |
Functional ≤ 10μM
|
Z81020-4-O |
HepG2 (Hepatoblastoma Cells) (cluster #4 Of 8), Other |
Other |
1 |
0.45 |
Functional ≤ 10μM
|
Z81034-3-O |
A2780 (Ovarian Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
3000 |
0.28 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
360 |
0.32 |
Functional ≤ 10μM
|
Z81199-1-O |
NCI-H446 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
1000 |
0.30 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
1800 |
0.29 |
Functional ≤ 10μM
|
Z81252-7-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #7 Of 11), Other |
Other |
3000 |
0.28 |
Functional ≤ 10μM
|
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
3200 |
0.27 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.03 |
5.3 |
-15.7 |
4 |
7 |
0 |
106 |
376.416 |
7 |
↓
|
Lo
Low (pH 4.5-6)
|
2.03 |
5.76 |
-45.32 |
5 |
7 |
1 |
108 |
377.424 |
7 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
HS90A-1-E |
Heat Shock Protein HSP 90-alpha (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
775 |
0.21 |
Binding ≤ 10μM
|
HS90B-1-E |
Heat Shock Protein HSP 90-beta (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
670 |
0.22 |
Binding ≤ 10μM
|
HSP90-1-E |
Heat Shock Protein HSP 90 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2000 |
0.20 |
Binding ≤ 10μM
|
ERBB2-3-E |
Receptor Protein-tyrosine Kinase ErbB-2 (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
50 |
0.26 |
Functional ≤ 10μM
|
ESR1-2-E |
Estrogen Receptor Alpha (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
60 |
0.25 |
Functional ≤ 10μM
|
ESR2-1-E |
Estrogen Receptor Beta (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
60 |
0.25 |
Functional ≤ 10μM
|
HS90A-1-E |
Heat Shock Protein HSP 90-alpha (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
60 |
0.25 |
Functional ≤ 10μM
|
HS90B-1-E |
Heat Shock Protein HSP 90-beta (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
60 |
0.25 |
Functional ≤ 10μM
|
HSP82-1-F |
Heat Shock Protein HSP 90 (HSP82) (cluster #1 Of 1), Fungal |
Fungi |
4800 |
0.19 |
Binding ≤ 10μM
|
Z50347-1-O |
Saccharomyces Cerevisiae (cluster #1 Of 1), Other |
Other |
4800 |
0.19 |
Binding ≤ 10μM
|
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
200 |
0.23 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
25 |
0.27 |
Functional ≤ 10μM
|
Z80186-4-O |
K562 (Erythroleukemia Cells) (cluster #4 Of 11), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z80224-9-O |
MCF7 (Breast Carcinoma Cells) (cluster #9 Of 14), Other |
Other |
9600 |
0.18 |
Functional ≤ 10μM
|
Z80262-1-O |
NCI-H1975 (Bronchoalveolar Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
36 |
0.26 |
Functional ≤ 10μM |
Z80359-1-O |
P19 (cluster #1 Of 1), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
70 |
0.25 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
30 |
0.26 |
Functional ≤ 10μM |
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 10), Other |
Other |
3 |
0.30 |
Functional ≤ 10μM
|
Z81186-1-O |
LS174T (Colon Adencocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
450 |
0.22 |
Functional ≤ 10μM
|
Z81331-5-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #5 Of 6), Other |
Other |
6 |
0.29 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.52 |
3.25 |
-48.59 |
3 |
11 |
-1 |
170 |
559.636 |
5 |
↓
|
Ref
Reference (pH 7)
|
1.28 |
0.74 |
-46.33 |
3 |
11 |
-1 |
171 |
559.636 |
5 |
↓
|
Lo
Low (pH 4.5-6)
|
-0.88 |
4.88 |
-17.23 |
3 |
11 |
0 |
164 |
560.644 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 29 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.30 |
8.49 |
-20.4 |
4 |
3 |
1 |
56 |
314.412 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 16 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AURKA-1-E |
Serine/threonine-protein Kinase Aurora-A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
7400 |
0.29 |
Binding ≤ 10μM
|
CCNB1-1-E |
G2/mitotic-specific Cyclin B1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
480 |
0.35 |
Binding ≤ 10μM
|
CCNB2-1-E |
G2/mitotic-specific Cyclin B2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
480 |
0.35 |
Binding ≤ 10μM
|
CCNB3-1-E |
G2/mitotic-specific Cyclin B3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
480 |
0.35 |
Binding ≤ 10μM
|
CCND1-1-E |
G1/S-specific Cyclin D1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
925 |
0.34 |
Binding ≤ 10μM
|
CCND2-1-E |
G1/S-specific Cyclin D2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
925 |
0.34 |
Binding ≤ 10μM
|
CCND3-1-E |
G1/S-specific Cyclin D3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
925 |
0.34 |
Binding ≤ 10μM
|
CCNE1-1-E |
G1/S-specific Cyclin E1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
48 |
0.41 |
Binding ≤ 10μM
|
CCNE2-1-E |
G1/S-specific Cyclin E2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
48 |
0.41 |
Binding ≤ 10μM
|
CD11A-1-E |
PITSLRE Serine/threonine-protein Kinase CDC2L2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
48 |
0.41 |
Binding ≤ 10μM
|
CD11B-1-E |
PITSLRE Serine/threonine-protein Kinase CDC2L1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
98 |
0.39 |
Binding ≤ 10μM
|
CDK1-1-E |
Cyclin-dependent Kinase 1 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
480 |
0.35 |
Binding ≤ 10μM
|
CDK14-1-E |
Serine/threonine-protein Kinase PFTAIRE-1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
690 |
0.35 |
Binding ≤ 10μM
|
CDK16-1-E |
Serine/threonine-protein Kinase PCTAIRE-1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7 |
0.46 |
Binding ≤ 10μM
|
CDK17-1-E |
Serine/threonine-protein Kinase PCTAIRE-2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
13 |
0.44 |
Binding ≤ 10μM
|
CDK18-1-E |
Serine/threonine-protein Kinase PCTAIRE-3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
44 |
0.41 |
Binding ≤ 10μM
|
CDK19-1-E |
Cell Division Cycle 2-like Protein Kinase 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
950 |
0.34 |
Binding ≤ 10μM
|
CDK2-1-E |
Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
69 |
0.40 |
Binding ≤ 10μM
|
CDK3-1-E |
Cyclin-dependent Kinase 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
56 |
0.41 |
Binding ≤ 10μM
|
CDK4-1-E |
Cyclin-dependent Kinase 4 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
925 |
0.34 |
Binding ≤ 10μM
|
CDK5-1-E |
Cyclin-dependent Kinase 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
740 |
0.34 |
Binding ≤ 10μM
|
CDK7-1-E |
Cyclin-dependent Kinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
62 |
0.40 |
Binding ≤ 10μM
|
CDK8-1-E |
Cell Division Protein Kinase 8 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1200 |
0.33 |
Binding ≤ 10μM
|
CDK9-1-E |
Cyclin-dependent Kinase 9 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
76 |
0.40 |
Binding ≤ 10μM
|
CLK1-1-E |
Dual Specificty Protein Kinase CLK1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
410 |
0.36 |
Binding ≤ 10μM
|
CLK2-1-E |
Dual Specificity Protein Kinase CLK2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1100 |
0.33 |
Binding ≤ 10μM
|
CLK4-1-E |
Dual Specificity Protein Kinase CLK4 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
800 |
0.34 |
Binding ≤ 10μM
|
DCLK1-1-E |
Serine/threonine-protein Kinase DCLK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1600 |
0.32 |
Binding ≤ 10μM
|
DCLK2-1-E |
Serine/threonine-protein Kinase DCLK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1000 |
0.34 |
Binding ≤ 10μM
|
DCLK3-1-E |
Serine/threonine-protein Kinase DCLK3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1600 |
0.32 |
Binding ≤ 10μM
|
DYR1B-1-E |
Dual Specificity Tyrosine-phosphorylation-regulated Kinase 1B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
200 |
0.38 |
Binding ≤ 10μM
|
FLT3-1-E |
Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7400 |
0.29 |
Binding ≤ 10μM
|
GAK-1-E |
Serine/threonine-protein Kinase GAK (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1800 |
0.32 |
Binding ≤ 10μM
|
GSK3A-1-E |
Glycogen Synthase Kinase-3 Alpha (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
28 |
0.42 |
Binding ≤ 10μM
|
GSK3B-1-E |
Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic |
Eukaryotes |
37 |
0.42 |
Binding ≤ 10μM
|
IRAK3-1-E |
Interleukin-1 Receptor-associated Kinase 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2900 |
0.31 |
Binding ≤ 10μM
|
KC1D-1-E |
Casein Kinase I Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1800 |
0.32 |
Binding ≤ 10μM
|
KC1E-1-E |
Casein Kinase I Epsilon (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
950 |
0.34 |
Binding ≤ 10μM
|
KPCD1-1-E |
Protein Kinase C Mu (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
1200 |
0.33 |
Binding ≤ 10μM
|
KPCD2-1-E |
Serine/threonine-protein Kinase D2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3900 |
0.30 |
Binding ≤ 10μM
|
KPCD3-1-E |
Protein Kinase C Nu (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
750 |
0.34 |
Binding ≤ 10μM
|
MELK-1-E |
Maternal Embryonic Leucine Zipper Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5600 |
0.29 |
Binding ≤ 10μM
|
MK04-1-E |
Mitogen-activated Protein Kinase 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4100 |
0.30 |
Binding ≤ 10μM
|
MK06-1-E |
Mitogen-activated Protein Kinase 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
500 |
0.35 |
Binding ≤ 10μM
|
MK07-1-E |
Mitogen-activated Protein Kinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
650 |
0.35 |
Binding ≤ 10μM
|
MK15-1-E |
Mitogen-activated Protein Kinase 15 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
120 |
0.39 |
Binding ≤ 10μM
|
MKNK1-1-E |
MAP Kinase-interacting Serine/threonine-protein Kinase MNK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3800 |
0.30 |
Binding ≤ 10μM
|
MYLK-1-E |
Myosin Light Chain Kinase, Smooth Muscle (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1700 |
0.32 |
Binding ≤ 10μM
|
MYLK2-1-E |
Myosin Light Chain Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
980 |
0.34 |
Binding ≤ 10μM
|
NUAK2-1-E |
NUAK Family SNF1-like Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1700 |
0.32 |
Binding ≤ 10μM
|
PAK3-1-E |
Serine/threonine-protein Kinase PAK 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3500 |
0.31 |
Binding ≤ 10μM
|
PHKG1-1-E |
Phosphorylase Kinase Gamma Subunit 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3800 |
0.30 |
Binding ≤ 10μM
|
ST17A-1-E |
Serine/threonine-protein Kinase 17A (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
440 |
0.36 |
Binding ≤ 10μM
|
STK36-1-E |
Serine/threonine-protein Kinase 36 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
260 |
0.37 |
Binding ≤ 10μM
|
TGFR2-1-E |
TGF-beta Receptor Type II (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2400 |
0.31 |
Binding ≤ 10μM
|
Z81034-1-O |
A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
95 |
0.39 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.17 |
-4.36 |
-55.93 |
3 |
6 |
1 |
84 |
381.547 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
ABL1-1-E |
Tyrosine-protein Kinase ABL (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
160 |
0.41 |
Binding ≤ 10μM
|
ABL2-1-E |
Tyrosine-protein Kinase ABL2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
160 |
0.41 |
Binding ≤ 10μM
|
AURKA-3-E |
Serine/threonine-protein Kinase Aurora-A (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
73 |
0.43 |
Binding ≤ 10μM
|
AURKB-1-E |
Serine/threonine-protein Kinase Aurora-B (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
57 |
0.44 |
Binding ≤ 10μM
|
CCNB1-1-E |
G2/mitotic-specific Cyclin B1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
80 |
0.43 |
Binding ≤ 10μM
|
CCNB2-1-E |
G2/mitotic-specific Cyclin B2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
80 |
0.43 |
Binding ≤ 10μM
|
CCNE1-1-E |
G1/S-specific Cyclin E1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2 |
0.53 |
Binding ≤ 10μM
|
CCNE2-1-E |
G1/S-specific Cyclin E2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2 |
0.53 |
Binding ≤ 10μM
|
CCNH-1-E |
Cyclin H (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
70 |
0.44 |
Binding ≤ 10μM
|
CCNT1-1-E |
Cyclin T1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4 |
0.51 |
Binding ≤ 10μM
|
CDK1-1-E |
Cyclin-dependent Kinase 1 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
80 |
0.43 |
Binding ≤ 10μM
|
CDK2-1-E |
Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
2 |
0.53 |
Binding ≤ 10μM
|
CDK4-1-E |
Cyclin-dependent Kinase 4 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
53 |
0.44 |
Binding ≤ 10μM
|
CDK7-1-E |
Cyclin-dependent Kinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
70 |
0.44 |
Binding ≤ 10μM
|
CDK9-1-E |
Cyclin-dependent Kinase 9 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
4 |
0.51 |
Binding ≤ 10μM
|
GSK3B-1-E |
Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic |
Eukaryotes |
20 |
0.47 |
Binding ≤ 10μM
|
Z104295-1-O |
Cyclin-dependent Kinase 4/cyclin D1 (cluster #1 Of 2), Other |
Other |
53 |
0.44 |
Binding ≤ 10μM
|
Z50587-1-O |
Homo Sapiens (cluster #1 Of 9), Other |
Other |
300 |
0.40 |
Functional ≤ 10μM
|
Z81034-1-O |
A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
48 |
0.45 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.81 |
-2.06 |
-14.33 |
3 |
8 |
0 |
122 |
328.357 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CCNB1-2-E |
G2/mitotic-specific Cyclin B1 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
6 |
0.46 |
Binding ≤ 10μM
|
CCNB2-2-E |
G2/mitotic-specific Cyclin B2 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
6 |
0.46 |
Binding ≤ 10μM
|
CCNB3-2-E |
G2/mitotic-specific Cyclin B3 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
6 |
0.46 |
Binding ≤ 10μM
|
CCND1-1-E |
G1/S-specific Cyclin D1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
230 |
0.37 |
Binding ≤ 10μM
|
CCND2-1-E |
G1/S-specific Cyclin D2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
230 |
0.37 |
Binding ≤ 10μM
|
CCND3-1-E |
G1/S-specific Cyclin D3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
230 |
0.37 |
Binding ≤ 10μM
|
CCNE1-2-E |
G1/S-specific Cyclin E1 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
9 |
0.45 |
Binding ≤ 10μM
|
CCNE2-2-E |
G1/S-specific Cyclin E2 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
9 |
0.45 |
Binding ≤ 10μM
|
CDK1-3-E |
Cyclin-dependent Kinase 1 (cluster #3 Of 4), Eukaryotic |
Eukaryotes |
6 |
0.46 |
Binding ≤ 10μM
|
CDK2-5-E |
Cyclin-dependent Kinase 2 (cluster #5 Of 5), Eukaryotic |
Eukaryotes |
9 |
0.45 |
Binding ≤ 10μM
|
CDK4-2-E |
Cyclin-dependent Kinase 4 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
230 |
0.37 |
Binding ≤ 10μM
|
Z81034-3-O |
A2780 (Ovarian Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
760 |
0.34 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.22 |
9.77 |
-10.35 |
1 |
5 |
0 |
68 |
345.349 |
6 |
↓
|
Mid
Mid (pH 6-8)
|
4.22 |
10.03 |
-34.41 |
2 |
5 |
1 |
69 |
346.357 |
6 |
↓
|
Mid
Mid (pH 6-8)
|
4.22 |
10.03 |
-35.9 |
2 |
5 |
1 |
69 |
346.357 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.36 |
-2.14 |
-16.54 |
5 |
9 |
0 |
150 |
356.367 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.08 |
-4.76 |
-55.17 |
4 |
9 |
1 |
97 |
502.643 |
6 |
↓
|
Hi
High (pH 8-9.5)
|
1.16 |
4.7 |
-95.23 |
7 |
8 |
2 |
122 |
456.497 |
5 |
↓
|
|
|
Analogs
-
36184686
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
KIF11-1-E |
Kinesin-like Protein 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2 |
0.43 |
Binding ≤ 10μM
|
KIF11-1-E |
Kinesin-like Protein 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
8 |
0.40 |
Binding ≤ 10μM
|
Z81034-3-O |
A2780 (Ovarian Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
5 |
0.42 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.74 |
9.84 |
-50.56 |
3 |
5 |
1 |
64 |
387.454 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.03 |
2.82 |
-4.03 |
0 |
0 |
0 |
0 |
278.467 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.23 |
8.24 |
-10.58 |
1 |
2 |
0 |
29 |
311.331 |
2 |
↓
|
Mid
Mid (pH 6-8)
|
3.23 |
9.57 |
-53.7 |
2 |
2 |
1 |
34 |
312.339 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 8 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
ABL1-1-E |
Tyrosine-protein Kinase ABL (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
25 |
0.30 |
Binding ≤ 10μM
|
AURKA-1-E |
Serine/threonine-protein Kinase Aurora-A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
AURKB-1-E |
Serine/threonine-protein Kinase Aurora-B (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
79 |
0.28 |
Binding ≤ 10μM
|
AURKC-1-E |
Serine/threonine-protein Kinase Aurora-C (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
61 |
0.29 |
Binding ≤ 10μM
|
CDK2-1-E |
Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
462 |
0.25 |
Binding ≤ 10μM
|
FGFR1-1-E |
Fibroblast Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
47 |
0.29 |
Binding ≤ 10μM
|
FLT3-1-E |
Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
669 |
0.25 |
Binding ≤ 10μM
|
KIT-1-E |
Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
407 |
0.26 |
Binding ≤ 10μM
|
LCK-1-E |
Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
155 |
0.27 |
Binding ≤ 10μM
|
NTRK1-1-E |
Nerve Growth Factor Receptor Trk-A (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
30 |
0.30 |
Binding ≤ 10μM
|
PLK1-1-E |
Serine/threonine-protein Kinase PLK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3500 |
0.22 |
Binding ≤ 10μM
|
RET-1-E |
Tyrosine-protein Kinase Receptor RET (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
31 |
0.30 |
Binding ≤ 10μM
|
SLK-1-E |
Serine/threonine-protein Kinase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
621 |
0.25 |
Binding ≤ 10μM
|
VGFR2-1-E |
Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
432 |
0.25 |
Binding ≤ 10μM
|
VGFR3-1-E |
Vascular Endothelial Growth Factor Receptor 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
161 |
0.27 |
Binding ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
80 |
0.28 |
Functional ≤ 10μM
|
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
80 |
0.28 |
Functional ≤ 10μM
|
Z81034-3-O |
A2780 (Ovarian Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
28 |
0.30 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
140 |
0.27 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.82 |
-4.38 |
-57.95 |
3 |
9 |
1 |
94 |
475.573 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 2 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
HDA10-3-E |
Histone Deacetylase 10 (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
59 |
0.46 |
Binding ≤ 10μM |
HDA11-1-E |
Histone Deacetylase 11 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
27 |
0.48 |
Binding ≤ 10μM |
HDAC1-2-E |
Histone Deacetylase 1 (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
63 |
0.46 |
Binding ≤ 10μM |
HDAC2-2-E |
Histone Deacetylase 2 (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
22 |
0.49 |
Binding ≤ 10μM |
HDAC3-1-E |
Histone Deacetylase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
46 |
0.47 |
Binding ≤ 10μM
|
HDAC4-3-E |
Histone Deacetylase 4 (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
380 |
0.41 |
Binding ≤ 10μM
|
HDAC5-3-E |
Histone Deacetylase 5 (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
25 |
0.48 |
Binding ≤ 10μM |
HDAC6-1-E |
Histone Deacetylase 6 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
15 |
0.50 |
Binding ≤ 10μM
|
HDAC7-1-E |
Histone Deacetylase 7 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
75 |
0.45 |
Binding ≤ 10μM
|
HDAC8-2-E |
Histone Deacetylase 8 (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
25 |
0.48 |
Binding ≤ 10μM
|
HDAC9-1-E |
Histone Deacetylase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
250 |
0.42 |
Binding ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
450 |
0.40 |
Functional ≤ 10μM |
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
600 |
0.40 |
Functional ≤ 10μM |
Z81034-3-O |
A2780 (Ovarian Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
670 |
0.39 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.19 |
2.64 |
-20.95 |
3 |
6 |
0 |
95 |
318.354 |
5 |
↓
|
Hi
High (pH 8-9.5)
|
2.19 |
2.69 |
-59.56 |
2 |
6 |
-1 |
98 |
317.346 |
5 |
↓
|
Hi
High (pH 8-9.5)
|
2.19 |
3.91 |
-108.48 |
1 |
6 |
-2 |
100 |
316.338 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 150 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.90 |
5.39 |
-13.16 |
0 |
2 |
0 |
26 |
180.21 |
0 |
↓
|
Lo
Low (pH 4.5-6)
|
1.90 |
5.91 |
-29.73 |
1 |
2 |
1 |
27 |
181.218 |
0 |
↓
|
|